Similar Articles
1091 Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma
1092 Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells
1093 Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
1094 Biological features and biomarkers in hepatocellular carcinoma
1095 Optimal combination of antiangiogenic therapy for hepatocellular carcinoma
1096 Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?
1097 Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums
1098 Current and future treatments for hepatocellular carcinoma
1099 Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma
1100 Current management of patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA